← Back to headlines

Doliprane Recall for Infants Due to Pipette Manufacturing Defect
Batches of drinkable Doliprane for infants and young children are being recalled in France due to a manufacturing defect where the graduations on the pipettes can gradually erase after rinsing.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
